October 12, 2020

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.

May 9, 2023

Hamilton County is bucking a national trend by seeing a drop in opioid deaths and overdoses. Rick Ryan, MD, of the Department of Emergency Medicine in the College of Medicine was interviewed about this by WLWT.

October 2, 2023

Spectrum News and Local 12 reported on research out of UC investigating the impact of a naloxone distribution collaborative.

October 24, 2023

The Cincinnati region is seeing an uptick in reports of fentanyl tainted with the horse tranquilizer xylazine. Cincinnati.com interviewed several local experts on the topic, including Richard Ryan, MD, of the Department of Emergency Medicine at the UC College of Medicine.

June 24, 2024

The University of Cincinnati's Caroline Freiermuth spoke with Spectrum News about how to look for signs of heat-related illness.

May 26, 2023

University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.

April 28, 2023

The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.

May 5, 2023

The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.

October 16, 2023

A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.

January 9, 2024

A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.